Investment Stage

Focus Areas

About Investor

Tomokatsu Hongo is a Corporate Officer at Keio Innovation Initiative and is based in Tokyo. His investment focus includes BioTech and Medical Device companies at the Seed and Series A stages. He works with founders who are translating scientific and clinical innovation into products that can improve healthcare outcomes. Tomokatsu typically invests between $500K and $3.5M, with a preferred commitment of approximately $2.5M. As a lead investor, he contributes to evaluating scientific potential, commercial readiness, and the financing needs of each company. Through Keio Innovation Initiative, he helps healthcare ventures progress from research and development toward market adoption.